Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 87; no. 12; pp. 6604 - 6614
Main Authors Chan, Renee W. Y., Chan, Michael C. W., Agnihothram, Sudhakar, Chan, Louisa L. Y., Kuok, Denise I. T., Fong, Joanne H. M., Guan, Y., Poon, Leo L. M., Baric, Ralph S., Nicholls, John M., Peiris, J. S. Malik
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection.
Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection.Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C virus EMC (HCoV-EMC), and 7 of them were fatal. The transmissibility and pathogenesis of HCoV-EMC remain poorly understood, and elucidating its cellular tropism in human respiratory tissues will provide mechanistic insights into the key cellular targets for virus propagation and spread. We utilized ex vivo cultures of human bronchial and lung tissue specimens to investigate the tissue tropism and virus replication kinetics following experimental infection with HCoV-EMC compared with those following infection with human coronavirus 229E (HCoV-229E) and severe acute respiratory syndrome coronavirus (SARS-CoV). The innate immune responses elicited by HCoV-EMC were also investigated. HCoV-EMC productively replicated in human bronchial and lung ex vivo organ cultures. While SARS-CoV productively replicated in lung tissue, replication in human bronchial tissue was limited. Immunohistochemistry revealed that HCoV-EMC infected nonciliated bronchial epithelium, bronchiolar epithelial cells, alveolar epithelial cells, and endothelial cells. Transmission electron microscopy showed virions within the cytoplasm of bronchial epithelial cells and budding virions from alveolar epithelial cells (type II). In contrast, there was minimal HCoV-229E infection in these tissues. HCoV-EMC failed to elicit strong type I or III interferon (IFN) or proinflammatory innate immune responses in ex vivo respiratory tissue cultures. Treatment of human lung tissue ex vivo organ cultures with type I IFNs (alpha and beta IFNs) at 1 h postinfection reduced the replication of HCoV-EMC, suggesting a potential therapeutic use of IFNs for treatment of human infection.
Author Joanne H. M. Fong
Renee W. Y. Chan
Louisa L. Y. Chan
Leo L. M. Poon
Denise I. T. Kuok
John M. Nicholls
Y. Guan
Michael C. W. Chan
Ralph S. Baric
Sudhakar Agnihothram
J. S. Malik Peiris
Author_xml – sequence: 1
  givenname: Renee W. Y.
  surname: Chan
  fullname: Chan, Renee W. Y.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China
– sequence: 2
  givenname: Michael C. W.
  surname: Chan
  fullname: Chan, Michael C. W.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
– sequence: 3
  givenname: Sudhakar
  surname: Agnihothram
  fullname: Agnihothram, Sudhakar
  organization: Departments of Epidemiology and Microbiology and Immunology, Gillings School of Global Public Health, and School of Medicine, The University of North Carolina, Chapel Hill, North Carolina, USA
– sequence: 4
  givenname: Louisa L. Y.
  surname: Chan
  fullname: Chan, Louisa L. Y.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
– sequence: 5
  givenname: Denise I. T.
  surname: Kuok
  fullname: Kuok, Denise I. T.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
– sequence: 6
  givenname: Joanne H. M.
  surname: Fong
  fullname: Fong, Joanne H. M.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
– sequence: 7
  givenname: Y.
  surname: Guan
  fullname: Guan, Y.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
– sequence: 8
  givenname: Leo L. M.
  surname: Poon
  fullname: Poon, Leo L. M.
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
– sequence: 9
  givenname: Ralph S.
  surname: Baric
  fullname: Baric, Ralph S.
  organization: Departments of Epidemiology and Microbiology and Immunology, Gillings School of Global Public Health, and School of Medicine, The University of North Carolina, Chapel Hill, North Carolina, USA
– sequence: 10
  givenname: John M.
  surname: Nicholls
  fullname: Nicholls, John M.
  organization: Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China
– sequence: 11
  givenname: J. S. Malik
  surname: Peiris
  fullname: Peiris, J. S. Malik
  organization: Centre of Influenza Research and School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23552422$$D View this record in MEDLINE/PubMed
BookMark eNqFkktvEzEUhS1URNPCjjWyWLFgip-TyQYJopYGRVRCpWJn3czcSVzN2MH2hPYH8L9xHlSAhPDGj_vdo2P7nJAj5x0S8pyzM85F9ebjzeyM5TEpuHxERpxNqkJrro7IiDEhCi2rr8fkJMZbxrhSpXpCjoXUWighRuTHdfBrG3vqWwquoTPnICGd9f3gkH7GuPYuYqTJ07RC-slvsKOXQw-OvscEtQ_ewcaGIdK5dQhLpFN6s9tbdwDP7_LJxu_UbIDkwz29CstcmQ5dGgLGp-RxC13EZ4f5lHy5OL-eXhbzqw-z6bt5USulUiEBpFhwhRLUotECmNKSV02T17qGBkEw0K0oaykqLfW41gvJsBUNl-MJ0_KUvN3rrodFj02NLgXozDrYHsK98WDNnxVnV2bpN0aW45LzrcCrg0Dw3waMyfQ21th14NAP0eQHlnIsGav-j0pdTnT2LzL64ndbD35-fVMGXu-BOvgYA7YPCGdmmwKTU2B2Kci6GRd_4bVNkKzfXsp2_2p6uW9a2eXquw1oIPbmdmNNNTZcmLJkSv4EcGvBXw
CitedBy_id crossref_primary_10_1128_JVI_03427_14
crossref_primary_10_1111_2049_632X_12166
crossref_primary_10_21307_PM_2018_57_1_022
crossref_primary_10_1099_vir_0_061911_0
crossref_primary_10_1016_j_intimp_2020_107171
crossref_primary_10_1074_jbc_M114_609644
crossref_primary_10_1038_srep35401
crossref_primary_10_1146_annurev_med_051215_031152
crossref_primary_10_2217_fvl_2016_0060
crossref_primary_10_1186_s12879_016_1492_4
crossref_primary_10_1016_S1473_3099_14_70828_X
crossref_primary_10_1128_JVI_03607_14
crossref_primary_10_1128_mBio_00650_13
crossref_primary_10_1016_j_bbalip_2020_158849
crossref_primary_10_1016_j_virol_2014_02_018
crossref_primary_10_1016_S1473_3099_13_70159_2
crossref_primary_10_1097_MCP_0000000000000046
crossref_primary_10_1093_jac_dkw338
crossref_primary_10_1016_j_antiviral_2018_05_007
crossref_primary_10_1016_S1473_3099_13_70154_3
crossref_primary_10_5897_JVMAH2015_0454
crossref_primary_10_4049_jimmunol_1901489
crossref_primary_10_1371_journal_ppat_1009229
crossref_primary_10_1016_j_ijbiomac_2021_02_070
crossref_primary_10_1128_mBio_01174_14
crossref_primary_10_1016_j_jbc_2022_101635
crossref_primary_10_12998_wjcc_v9_i19_5135
crossref_primary_10_1089_jir_2020_0187
crossref_primary_10_1016_S2213_2600_13_70138_3
crossref_primary_10_1016_j_jfma_2013_05_010
crossref_primary_10_3389_fvets_2019_00034
crossref_primary_10_1099_vir_0_055533_0
crossref_primary_10_1007_s00251_022_01261_w
crossref_primary_10_1016_j_csbj_2024_01_009
crossref_primary_10_1126_sciadv_aao4966
crossref_primary_10_1128_JVI_01055_13
crossref_primary_10_1186_s12985_024_02332_y
crossref_primary_10_1038_s41556_021_00710_0
crossref_primary_10_1016_j_cytogfr_2014_06_005
crossref_primary_10_1186_s13054_016_1234_4
crossref_primary_10_1007_s15010_013_0509_9
crossref_primary_10_1371_journal_ppat_1003595
crossref_primary_10_3390_v14010164
crossref_primary_10_1002_rmv_2206
crossref_primary_10_1073_pnas_1619109114
crossref_primary_10_1128_JVI_02143_16
crossref_primary_10_3389_fphar_2020_600369
crossref_primary_10_1038_s41598_017_11736_6
crossref_primary_10_1128_mBio_00531_13
crossref_primary_10_1016_j_antiviral_2013_10_002
crossref_primary_10_1016_S0140_6736_15_60454_8
crossref_primary_10_17816_brmma72051
crossref_primary_10_1074_jbc_AC120_013788
crossref_primary_10_1093_infdis_jit328
crossref_primary_10_1007_s13365_021_00998_6
crossref_primary_10_1016_j_antiviral_2015_07_005
crossref_primary_10_1007_s11356_021_12553_1
crossref_primary_10_1038_s44298_024_00018_4
crossref_primary_10_1093_cvr_cvaa209
crossref_primary_10_1177_03009858221095270
crossref_primary_10_1073_pnas_1310744110
crossref_primary_10_1093_infdis_jit609
crossref_primary_10_3390_v15040907
crossref_primary_10_1002_rmv_1748
crossref_primary_10_1016_j_ccc_2013_07_003
crossref_primary_10_1128_AAC_03011_14
crossref_primary_10_3201_eid2203_151437
crossref_primary_10_3390_cells10030530
crossref_primary_10_1186_s12931_017_0567_0
crossref_primary_10_1007_s13238_013_3096_8
crossref_primary_10_1038_nrd_2015_37
crossref_primary_10_1371_journal_ppat_1006838
crossref_primary_10_1177_17534666231162252
crossref_primary_10_2217_fvl_2018_0201
crossref_primary_10_1016_j_biopha_2021_111352
crossref_primary_10_1208_s12249_021_02062_2
crossref_primary_10_4049_immunohorizons_2200065
crossref_primary_10_1128_JVI_03649_13
crossref_primary_10_1128_CMR_00102_14
crossref_primary_10_1073_pnas_1323279111
crossref_primary_10_3389_fimmu_2024_1358885
crossref_primary_10_1016_j_antiviral_2013_08_015
crossref_primary_10_1038_emi_2016_33
crossref_primary_10_1186_s13567_016_0354_9
crossref_primary_10_3389_fimmu_2018_00205
crossref_primary_10_1371_journal_ppat_1008737
crossref_primary_10_1016_j_ccm_2016_11_007
crossref_primary_10_1016_j_coviro_2014_03_011
crossref_primary_10_1016_S2213_2600_20_30193_4
crossref_primary_10_1016_j_arr_2020_101234
crossref_primary_10_1093_infdis_jit504
crossref_primary_10_3390_pathogens9120989
crossref_primary_10_1146_annurev_pathol_012414_040501
crossref_primary_10_12688_f1000research_11827_1
crossref_primary_10_12688_f1000research_25390_1
crossref_primary_10_1371_journal_ppat_1005982
crossref_primary_10_1155_2019_6491738
crossref_primary_10_1016_S2213_2600_14_70158_4
crossref_primary_10_3389_fpubh_2021_756049
crossref_primary_10_1073_pnas_1311542110
crossref_primary_10_1128_JVI_00676_14
crossref_primary_10_1093_cid_ciaa453
crossref_primary_10_1016_j_virusres_2015_01_021
crossref_primary_10_1186_1471_2164_15_1161
crossref_primary_10_1186_s12985_015_0446_6
crossref_primary_10_1002_path_4458
crossref_primary_10_1002_jnr_24752
crossref_primary_10_1002_mco2_26
crossref_primary_10_1097_FCH_0000000000000082
crossref_primary_10_1038_srep17554
crossref_primary_10_1093_infdis_jiv499
crossref_primary_10_1016_j_scitotenv_2020_143352
crossref_primary_10_1111_irv_12173
crossref_primary_10_1016_j_jiph_2021_08_015
crossref_primary_10_1099_vir_0_059014_0
crossref_primary_10_4193_Rhin20_610
crossref_primary_10_1097_MCP_0000000000000153
crossref_primary_10_1186_s12879_017_2253_8
crossref_primary_10_4103_ijcm_ijcm_460_22
crossref_primary_10_1128_JVI_00099_20
crossref_primary_10_3390_v13061139
crossref_primary_10_1016_j_jiph_2017_08_009
crossref_primary_10_1186_s12985_016_0479_5
crossref_primary_10_1007_s12275_017_7026_y
crossref_primary_10_1016_j_prrv_2015_04_002
crossref_primary_10_1016_j_ajpath_2015_09_014
crossref_primary_10_1073_pnas_2410630122
crossref_primary_10_7554_eLife_66417
crossref_primary_10_1016_j_vetmic_2019_06_001
crossref_primary_10_1111_ene_14277
crossref_primary_10_1016_j_clinmicnews_2014_07_002
crossref_primary_10_1016_j_virusres_2016_11_011
crossref_primary_10_3390_v11010059
crossref_primary_10_1128_JVI_03036_15
crossref_primary_10_3390_v11030280
Cites_doi 10.2217/17460794.4.1.71
10.1186/1743-422X-10-66
10.1111/j.1750-2659.2010.00155.x
10.1073/pnas.0711942105
10.1182/blood-2004-10-4166
10.1016/S0140-6736(03)13973-6
10.1001/jama.290.24.3222
10.1128/JVI.01782-06
10.1128/JVI.79.24.15511-15524.2005
10.2807/ese.17.40.20290-en
10.1165/rcmb.2012-0339OC
10.1080/00365540410021144
10.1128/JVI.79.12.7819-7826.2005
10.1016/j.virol.2004.08.011
10.1016/j.antiviral.2011.07.011
10.1371/journal.pmed.0030027
10.1038/nm1529
10.1128/JVI.05662-11
10.1056/NEJMoa1211721
10.1016/j.antiviral.2010.11.007
10.1086/382597
10.1373/clinchem.2003.023663
10.1371/journal.ppat.1000756
10.1016/S0140-6736(02)11772-7
10.1371/journal.ppat.1002705
10.1128/JCM.02614-05
10.1128/JVI.06189-11
10.1128/mBio.00611-12
10.1371/journal.pone.0013927
10.1016/j.coviro.2012.04.004
10.2807/ese.17.39.20282-en
10.2807/ese.17.39.20285-en
10.1007/BF00194614
10.1016/j.jinf.2012.10.002
10.1128/mBio.00473-12
10.1038/nm1001
10.3201/eid1903.121503
10.2353/ajpath.2010.091087
10.1006/meth.2001.1262
10.1016/j.virol.2007.09.045
10.1038/nm1024
ContentType Journal Article
Copyright Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
Copyright_xml – notice: Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
DOI 10.1128/JVI.00009-13
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList
CrossRef
MEDLINE - Academic

MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 6614
ExternalDocumentID PMC3676115
23552422
10_1128_JVI_00009_13
jvi_87_12_6604
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI075297
– fundername: NIAID NIH HHS
  grantid: U54-AI057157
– fundername: NIAID NIH HHS
  grantid: R01AI085524
– fundername: NIAID NIH HHS
  grantid: U54 AI057157
– fundername: NIAID NIH HHS
  grantid: R01 AI085524
– fundername: NIAID NIH HHS
  grantid: R01AI075297
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
.55
.GJ
3O-
41~
6TJ
AAYJJ
ADXHL
AFFNX
AI.
C1A
CGR
CUY
CVF
D0S
ECM
EIF
MVM
NPM
OHT
VH1
X7M
Y6R
ZGI
ZXP
7X8
7T5
7U9
H94
5PM
ID FETCH-LOGICAL-c444t-3aa32b14e3a4bd52a045318ddd525cadea20a5f26c3285357c5b30ef2d1379053
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 17:44:28 EDT 2025
Thu Jul 10 19:12:11 EDT 2025
Fri Jul 11 08:14:23 EDT 2025
Mon Jul 21 05:57:22 EDT 2025
Thu Apr 24 23:06:35 EDT 2025
Tue Jul 01 01:02:23 EDT 2025
Wed May 18 15:26:13 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c444t-3aa32b14e3a4bd52a045318ddd525cadea20a5f26c3285357c5b30ef2d1379053
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
R.W.Y.C. and M.C.W.C. contributed equally to this article.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3676115
PMID 23552422
PQID 1356955312
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1356955312
crossref_citationtrail_10_1128_JVI_00009_13
proquest_miscellaneous_1443373008
highwire_asm_jvi_87_12_6604
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3676115
pubmed_primary_23552422
crossref_primary_10_1128_JVI_00009_13
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-06-01
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2013
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
WHO (e_1_3_2_13_2) 2012
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
Chan MC (e_1_3_2_7_2) 2011; 17
38497665 - J Virol. 2024 Mar 18;:e0037924
References_xml – ident: e_1_3_2_4_2
  doi: 10.2217/17460794.4.1.71
– ident: e_1_3_2_15_2
– ident: e_1_3_2_16_2
  doi: 10.1186/1743-422X-10-66
– ident: e_1_3_2_40_2
  doi: 10.1111/j.1750-2659.2010.00155.x
– ident: e_1_3_2_41_2
  doi: 10.1073/pnas.0711942105
– ident: e_1_3_2_3_2
  doi: 10.1182/blood-2004-10-4166
– ident: e_1_3_2_43_2
  doi: 10.1016/S0140-6736(03)13973-6
– ident: e_1_3_2_44_2
  doi: 10.1001/jama.290.24.3222
– ident: e_1_3_2_42_2
  doi: 10.1128/JVI.01782-06
– ident: e_1_3_2_6_2
  doi: 10.1128/JVI.79.24.15511-15524.2005
– ident: e_1_3_2_11_2
  doi: 10.2807/ese.17.40.20290-en
– ident: e_1_3_2_10_2
  doi: 10.1165/rcmb.2012-0339OC
– ident: e_1_3_2_24_2
  doi: 10.1080/00365540410021144
– ident: e_1_3_2_2_2
  doi: 10.1128/JVI.79.12.7819-7826.2005
– ident: e_1_3_2_27_2
  doi: 10.1016/j.virol.2004.08.011
– ident: e_1_3_2_39_2
  doi: 10.1016/j.antiviral.2011.07.011
– ident: e_1_3_2_9_2
  doi: 10.1371/journal.pmed.0030027
– ident: e_1_3_2_30_2
  doi: 10.1038/nm1529
– ident: e_1_3_2_23_2
  doi: 10.1128/JVI.05662-11
– ident: e_1_3_2_12_2
  doi: 10.1056/NEJMoa1211721
– ident: e_1_3_2_26_2
  doi: 10.1016/j.antiviral.2010.11.007
– ident: e_1_3_2_29_2
  doi: 10.1086/382597
– ident: e_1_3_2_32_2
  doi: 10.1373/clinchem.2003.023663
– ident: e_1_3_2_28_2
  doi: 10.1371/journal.ppat.1000756
– ident: e_1_3_2_33_2
  doi: 10.1016/S0140-6736(02)11772-7
– ident: e_1_3_2_35_2
  doi: 10.1371/journal.ppat.1002705
– ident: e_1_3_2_20_2
  doi: 10.1128/JCM.02614-05
– ident: e_1_3_2_34_2
  doi: 10.1128/JVI.06189-11
– ident: e_1_3_2_37_2
  doi: 10.1128/mBio.00611-12
– volume-title: Background and summary of novel coronavirus infection
  year: 2012
  ident: e_1_3_2_13_2
– volume: 17
  start-page: 31
  year: 2011
  ident: e_1_3_2_7_2
  article-title: Pathogenesis of SARS coronavirus infection using human lung epithelial cells: an in vitro model
  publication-title: Hong Kong Med. J
– ident: e_1_3_2_45_2
  doi: 10.1371/journal.pone.0013927
– ident: e_1_3_2_5_2
  doi: 10.1016/j.coviro.2012.04.004
– ident: e_1_3_2_14_2
  doi: 10.2807/ese.17.39.20282-en
– ident: e_1_3_2_19_2
  doi: 10.2807/ese.17.39.20285-en
– ident: e_1_3_2_38_2
  doi: 10.1007/BF00194614
– ident: e_1_3_2_18_2
  doi: 10.1016/j.jinf.2012.10.002
– ident: e_1_3_2_36_2
  doi: 10.1128/mBio.00473-12
– ident: e_1_3_2_25_2
  doi: 10.1038/nm1001
– ident: e_1_3_2_17_2
  doi: 10.3201/eid1903.121503
– ident: e_1_3_2_22_2
  doi: 10.2353/ajpath.2010.091087
– ident: e_1_3_2_31_2
  doi: 10.1006/meth.2001.1262
– ident: e_1_3_2_8_2
  doi: 10.1016/j.virol.2007.09.045
– ident: e_1_3_2_21_2
  doi: 10.1038/nm1024
– reference: 38497665 - J Virol. 2024 Mar 18;:e0037924
SSID ssj0014464
Score 2.4883578
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
Since April 2012, there have been 17 laboratory-confirmed human cases of respiratory disease associated with newly recognized human betacoronavirus lineage C...
SourceID pubmedcentral
proquest
pubmed
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6604
SubjectTerms Bronchi - cytology
Bronchi - virology
Cell Line
Coronavirus - drug effects
Coronavirus - genetics
Coronavirus - immunology
Coronavirus - physiology
Coronavirus 229E, Human - physiology
Coronavirus Infections - immunology
Coronavirus Infections - virology
Epithelial Cells - virology
Human coronavirus 229e
Humans
Immunity, Innate
Interferons - pharmacology
Lung - cytology
Lung - virology
Organ Culture Techniques
Receptors, Coronavirus
Receptors, Virus - metabolism
SARS coronavirus
Severe Acute Respiratory Syndrome - immunology
Severe Acute Respiratory Syndrome - virology
Severe acute respiratory syndrome-related coronavirus - physiology
Viral Tropism
Virus Replication
Virus-Cell Interactions
Title Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures
URI http://jvi.asm.org/content/87/12/6604.abstract
https://www.ncbi.nlm.nih.gov/pubmed/23552422
https://www.proquest.com/docview/1356955312
https://www.proquest.com/docview/1443373008
https://pubmed.ncbi.nlm.nih.gov/PMC3676115
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiQuiDehgBYJTpZDsg_HPpYoqCktB2hLOVnrFxgaO3KcqHDnr_I7mFmvHbstFXCxHO9ms858np3xznxDyAtY9EQwTJgdJBG3BbjXthe4iR1wJ5JcuDyMcUf34J2zeyT2TuRJr_erFbW0KoNB-OPSvJL_kSpcA7liluw_SLYZFC7AOcgXjiBhOP6djIt8gUUucC9fh_VmYDlaM0z5wHIMOvq1onDQoYz5Oj41b-1fxyWowgLM8HVarJbomscYvTOxjvVnZMDSHadncGWd69HqLXmdv2nIOE0I4kXzFsbpvLF_D0o1tj4OrE8DndLQSLqK27cmA2xst3xYRV_UN1VYO5-zFDPFCjWv2_bzVbpU1n53OPP2QleS6ESC1NtS7RjVg3TDQdXW3eg2c12IGFauSl0jGyrafG19bhZwg1vW0s6OU5U6vrhsMEyF2DueaTpLz67SY1sIWsw1hBhYZ2DTsM3iWQcMnFtTm0jHr-vUd8f-iPn449fIdQbujHb9Z2-b3S5wyUXNao93WCdoMPdVe05IXG0m0LWiambry7yk88G-Levp8Da5ZXBBdyoM3yG9OLtLblSFUL_fIz8NkmmeUEAyrZBMKyTTBsm0zCkgmWokUw1Qeg7J1CCZTqhGMk0z03F6RhHJtIVkqpFMayTfJ0dvpoeTXdsUCLFDIURpc6U4C0Yi5koEkWQK_BNYo6IIziWmlyg2VDJhTsgZmKVyHMqAD-OERSOOxHT8AdnK8ix-ROhYymgskkQqNxQwqDdkXhC6kYcmvgpGfWLVf7gfGvZ8LOJy6msvmrk-SMrXkvJHvE9eNr0XFWvMH_pt17Lz1XLud9HSJ89rcfqg9HEnT2VxvlrCN6XjSbhXdkUfITjHahRunzysINDMpYZRn4w74Gg6IOl8twUedE0-jwyP4EU-vnLm2-Tm5mF_QrbKYhU_BeO9DJ5p5P8G1CHxeg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tropism+of+and+Innate+Immune+Responses+to+the+Novel+Human+Betacoronavirus+Lineage+C+Virus+in+Human+Ex+Vivo+Respiratory+Organ+Cultures&rft.jtitle=Journal+of+Virology&rft.au=Renee+W.+Y.+Chan&rft.au=Michael+C.+W.+Chan&rft.au=Sudhakar+Agnihothram&rft.au=Louisa+L.+Y.+Chan&rft.date=2013-06-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=87&rft.issue=12&rft.spage=6604&rft_id=info:doi/10.1128%2FJVI.00009-13&rft_id=info%3Apmid%2F23552422&rft.externalDBID=n%2Fa&rft.externalDocID=jvi_87_12_6604
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon